Company Filing History:
Years Active: 2024
Title: Innovations in Diabetes Treatment by Moufida Ben-Nasr
Introduction
Moufida Ben-Nasr is an accomplished inventor based in Boston, MA. She has made significant contributions to the field of medical science, particularly in the treatment of type 1 diabetes and autoimmune diseases. Her innovative work focuses on the modulation of hematopoietic stem cells to improve patient outcomes.
Latest Patents
Moufida Ben-Nasr holds a patent for her groundbreaking invention titled "Treatment of type 1 diabetes and autoimmune diseases or disorders." This patent describes methods and compositions for producing modified, PD-L1 expressing hematopoietic stem cells. The invention includes techniques for modulating the expression of micro RNA that controls PD-L1 expression in these stem cells. Methods for achieving this modulation involve introducing a nucleic acid encoding a specific micro RNA or using an agent that inhibits a particular micro RNA.
Career Highlights
Moufida is currently associated with the Children's Medical Center Corporation, where she continues her research and development efforts. Her work is pivotal in advancing therapeutic strategies for challenging medical conditions.
Collaborations
Moufida collaborates with Paolo Fiorina, a fellow researcher, to further enhance the impact of their work in the medical field.
Conclusion
Moufida Ben-Nasr's innovative contributions to diabetes treatment exemplify the potential of scientific research to transform healthcare. Her dedication to improving patient outcomes through her patented methods is commendable.